Merck (MRK) Net Margin (2009 - 2026)
Merck (MRK) posted quarterly Net Margin of 25.84% for Q1 2026, down 5859.0% year-over-year from 0.45% in Q1 2025, and down 243.09% quarter-over-quarter from 18.06% in Q4 2025.
Merck (MRK) Net Margin (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Net Margin for 17 consecutive years, with 25.84% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin fell 5859.0% year-over-year to 25.84%; the TTM figure through Mar 2026 stood at 13.64% (down 1366.0% YoY), while the FY2025 annual figure was 28.09%, up 139.0% from the prior year.
- Net Margin slipped to 25.84% in Q1 2026 per MRK's latest filing, from 18.06% in the prior quarter.
- Across five years, Net Margin topped out at 33.89% in Q2 2024 and bottomed at 39.72% in Q2 2023.
- Historically, Net Margin has averaged 14.98% across 4 years, with a median of 23.96% in 2024.
- Annual changes were most pronounced in 2024 — Net Margin surged 7361 bps — and 2026, when it tumbled 5859 bps.
- Merck's Net Margin stood at 8.38% in 2023, then surged by 386 bps to 23.96% in 2024, then slipped by 25 bps to 18.06% in 2025, then plunged by 243 bps to 25.84% in 2026.
- Business Quant data shows MRK's Net Margin at 25.84% in Q1 2026, 18.06% in Q4 2025, and 33.5% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.58% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 5.17% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 2.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.05% |
| Mar 31, 2026 | -25.84% |
| Dec 31, 2025 | 18.06% |
| Sep 30, 2025 | 33.50% |
| Jun 30, 2025 | 28.01% |
| Mar 31, 2025 | 32.75% |
| Dec 31, 2024 | 23.96% |
| Sep 30, 2024 | 18.98% |
| Jun 30, 2024 | 33.89% |
| Mar 31, 2024 | 30.22% |
| Dec 31, 2023 | -8.38% |
| Sep 30, 2023 | 29.76% |
| Jun 30, 2023 | -39.72% |
| Mar 31, 2023 | 19.50% |
| Dec 31, 2021 | -0.44% |
| Jun 30, 2021 | 2.91% |
| Mar 31, 2021 | 4.08% |
| Dec 31, 2020 | 4.78% |
| Sep 30, 2020 | 5.66% |
| Jun 30, 2020 | 7.11% |